Tilaknagar Industries Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 4 Aug 2026 | Beverages | Market Cap: ₹12.4K Cr
For FY26, Imperial Blue (IB) is expected to witness a low to mid-single digit volume degrowth compared to FY25 due to tepid performance prior to acquisition. High-single digit volume growth expected for Imperial Blue (IB) in Q4 FY26.
From Tilaknagar Industries Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹576
Market Cap
₹12.4K Cr
P/E Ratio
54.9
How does Tilaknagar Industries Ltd rank in Beverages?
Compare Tilaknagar Industries Ltd against every Beverages company this quarter on revenue, margins and earnings-call signals.
Tilaknagar Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹664 Cr, net profit ₹-105 Cr.
Full financials →📊 Revenue & Sales Performance
- →For FY26, Imperial Blue (IB) is expected to witness a low to mid-single digit volume degrowth compared to FY25 due to tepid performance prior to acquisition.
- →In Q4 FY26, despite integration, a high-single digit volume growth for IB is anticipated.
- →For FY27, the combined business expects high-single digit to low-double digit volume growth.
- →Beyond FY27, low-double digit volume growth is projected over the next couple of years.
- →Revenue growth is expected to be approximately 150-200 basis points above volume growth.
- →Overall, Q3 FY26 saw a 76.1% YoY volume increase to 5.3 million cases; excluding IB, volumes increased 16.8%.
- →The combined business targets EBITDA margin expansion of 150-250 basis points over the next 24-36 months.
📈 Profitability & Margins
- →High-single digit volume growth expected for Imperial Blue (IB) in Q4 FY26.
- →Combined business volume growth guidance for FY27: high-single digit to low-double digit.
- →Beyond FY27: sustained low-double digit volume growth projected.
- →Revenue growth anticipated at approximately 150-200 basis points above volume growth for FY27 and onwards.
- →Consolidated EBITDA margins expected to expand by 150-250 bps over the next 24-36 months.
- →Margin expansion for acquired Imperial Blue business targeted at 250-350 bps over 24 months.
- →Net debt-to-EBITDA ratio projected to fall below 1.0x by FY29, indicating deleveraging.
- →Long-term return potential similar to past 5-7 years performance anticipated for shareholders.
- →Continuous focus on premiumization, new product development, and expanded distribution to drive profits and EPS growth.
🏗️ Capital Expenditure Plans
- →Prag distillery expanded facility is expected to be commissioned by end of Q4 FY26, targeting almost full utilization over the course of the year.
- →Approximately Rs. 10 crore of capital investment still pending related to Prag distillery.
- →License fees for Prag distillery have been fully paid.
- →The company plans increased A&P investment (advertising & promotion) as part of margin expansion strategy but has not provided specific percentages yet.
- →Post Imperial Blue acquisition, the company is entering into new bottling and vendor arrangements to ensure business continuity and minimal disruption during integration.
- →Focus on cost-saving initiatives and organizational restructuring to leverage synergies and expand market presence.
- →No explicit future strategic investment outside the Imperial Blue acquisition and associated integration is detailed, but organic launches of whisky brands in promising segments are planned.
💰 Fundraising & Capital Structure
- →The company raised over Rs. 2,000 crore through a preferential allotment during the acquisition of Imperial Blue, duly approved by the Board and shareholders.
- →Debt of Rs. 2,100 crore was taken from banks and NBFCs with a principal moratorium for the first 2 years and balloon repayment at the end of tenure.
- →Warrants held by the promoter group will be converted in the upcoming fiscal year as part of the fundraising.
- →No specific mention of any new or future fundraising through debt or equity beyond these measures was made on the call.
- →The company is focused on integrating Imperial Blue and deleveraging the balance sheet, aiming to reduce net debt-to-EBITDA ratio below 1.0x by FY29.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Tilaknagar Industries Ltd Q3 FY26 results?
For FY26, Imperial Blue (IB) is expected to witness a low to mid-single digit volume degrowth compared to FY25 due to tepid performance prior to acquisition. High-single digit volume growth expected for Imperial Blue (IB) in Q4 FY26.
What is Tilaknagar Industries Ltd share price analysis?
Tilaknagar Industries Ltd currently shows a neutral. The stock trades at a P/E of 54.9 with a market cap of ₹12,397 Cr. Investors should review the full earnings analysis for detailed insights.
Is Tilaknagar Industries Ltd planning capital expenditure?
Prag distillery expanded facility is expected to be commissioned by end of Q4 FY26, targeting almost full utilization over the course of the year.
Keep Tilaknagar Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.